Download Brochure
Fill in your details to get instant access
We respect your privacy. No spam, ever.
Conference Overview
Unlocking the Future of Clinical Trials
The 17th Annual Clinical Trials Summit 2026 serves as India’s premier platform to explore rapid market expansion and cutting-edge research innovations. Join global industry leaders to bridge the gap between regulatory intent and real-world execution through patient-centric trial design.
Decentralised Trials (DCTs)
Evaluate the transition toward remote trial models while balancing innovation, cost-efficiency, and patient access.
Regulatory Reforms
Discuss the latest updates on ICH GCP E6(R3) guidelines and streamlined approval pathways in the Asia-Pacific region.
Technology and AI
Discover how artificial intelligence and digital tools are transforming trial design, data analysis, and success rates.
Inspection Readiness
Learn to build robust compliance frameworks and risk monitoring strategies to meet post-pandemic regulatory expectations.
Patient Centricity
Focus on integrating safety, trust, and prioritized patient needs into every stage of the clinical research ecosystem.
Real-World Evidence (RWE)
Learn how to harness RWD to answer critical questions and improve structured benefit-risk assessments.
Download Brochure
Fill in your details to get instant access
We respect your privacy. No spam, ever.
Bridging Innovation & Integrity: Shaping the Future of Patient-Centric Clinical Trials
India’s clinical trial market is expanding rapidly, valued at up to USD 2.1 billion in 2025 and projected to reach USD 4.3 billion by 2033. As a premier global research hub, India is leveraging a diverse patient population and regulatory streamlining to drive an 8-9% CAGR. The 17th Annual Clinical Trials Summit 2026 serves as a vital platform for professionals to explore future advancements, from decentralized trials to AI-driven designs. By fostering collaboration between industry leaders, academia, and regulatory bodies, the summit addresses real-world challenges in trial execution. Attendees will gain exclusive insights into the evolving healthcare outsourcing landscape and emerging patient-centric innovations.
Speakers
Attendees
Hrs NETWORKING
SESSIONS
OUR ATTENDEES
Trusted by Industry Leaders Worldwide
REGISTER ATTEND LEARN NETWORK SUCCEED
5 reasons to attend the events
We Simplify Planning, Boost Engagement, And Create Unforgettable Experiences.
Expert Insights
Learn from world-class leaders and high-level speakers across the clinical research ecosystem. Gain specialized knowledge on the latest business models and strategic industry developments.
Strategic Networking
Enjoy dedicated networking time to connect with decision-makers and global peers. Meet leading international vendors showcasing future products in the co-located exhibition.
Market Intelligence
Explore the rapidly expanding Indian clinical trial market, projected to reach up to USD 4.3 billion by 2033. Understand the growth drivers, including digital adoption and regulatory streamlining in the Asia-Pacific region.
Regulatory Mastery
Engage in deep dives regarding ICH GCP E6(R3) implementation and evolving regulatory reforms in India. Access practical strategies for maintaining inspection readiness and a culture of compliance.
Innovation Spotlight
Discover how AI and emerging technologies are transforming trial design and execution. Stay updated on cutting-edge trends like Decentralised Clinical Trials (DCTs) and Real-World Evidence (RWE).
Meet Our Expert Speakers
OUR EVENT SCHEDULE
08:30 – Coffee & Registration – An opportunity to meet and to network with your conference colleagues.
09:20 – Welcome Address
CHALLENGES & OPPORTUNITIES
09:30 – “ICH GCP E6(R3): Bridging the Gap Between Guideline Intent and Real‑World Implementation”
- Understanding the True Intent of ICH E6(R3)
- Identifying Current Implementation Gaps
- Commonly Overlooked Elements in R3
- Practical Barriers Across Sponsors, CROs, and Sites
- Actionable Strategies to Bridge the Gap
DIVAKAR KOLLI
Cipla
DECENTRALISATION
10:10 – Keynote Panel Discussion: Decentralised Clinical Trials at a Crossroads: Balancing Innovation, Cost, and Access
Moderator
OMPRAKASH S. SADHWANI
FDA (Maharashtra State) (Former)
Panellists
VAIBHAV SALVI
Sanofi
AMARNATH SUGUMARAN
Cipla
SACHIN SURYAWANSHI
Emcure Pharmaceutical
BAIDYANATH MISHRA
Dabur
11:00 – Morning Coffee/Tea & Discussion
PATIENT CENTRICITY
11:30 – DISCUSSION WITH EXPERTS: Putting Patients First: Integrating Safety, Trust, and Design Across Clinical Trials
Moderator
DYOTONA SEN
Galderma
Panellists
RAJENDRA KUMAR KASI
Glenmark Pharmaceuticals
MOHIT TRIVEDI
Sanofi
ISHAN PATEL
MSD India
MANGALA KOTNIS
Abbott (Former)
12:10 – Digital Clinical Trials Ecosystem: Integrating RWE, AI, and Centralized Monitoring for Smarter, Faster, and Safer Trials
SOMESH BOLEGAVE
SIRO Clintech
12:40 –Networking luncheon
SPONSOR – SITE – CRO – PATIENTS – REGULATORS
13:50 – DISCUSSION WITH EXPERTS: Sponsors, Sites, CROs, Patients, and Regulators - From Silos to Synergy: Working Together to Accelerate Clinical Trials
Moderator
SAKHARAM GARALE
RENOVARE Healthcare
Panellists
SHAILENDRA SACHAN
Teva Pharmaceuticals
K. MURUGANANTHAN
Novartis
ABHIJIT ANIL TRAILOKYA
Indoco Remedies
14:50 - Clinical Trials of Biosimilars and Antibody drug conjugates (ADCs)- Strategies and Updates
- Optimizing clinical confirmation strategies
- Early-phase dose optimization & biomarker selection
- Totality-of-evidence approach & indication extrapolation with Biosimilars
- Immunogenicity, switching, and real-world evidence
- Managing complex safety profiles
- Accelerated development and regulatory pathways
SHUBHADEEP SINHA
Hetero Labs
15:30 – Afternoon Tea/Coffee
DO IT RIGHT – OUTSOURCING / PARTNERSHIPS
16:00 – DISCUSSION WITH EXPERTS: From Vendors to Partners: Redefining Outsourcing in Clinical Trials. Building Strategic Partnerships for Clinical Trial Success
Moderator
RANJIT BARSHIKAR
QBD International, United Nations Adviser
Panellists
ANIL KUKREJA
Emcure Pharmaceuticals
JYOTSNA PATWARDHAN
Novartis
EMRAN KHAN
Sun Pharma Advanced Research Company
PADMA BALAKRISHNAN
Knowledgeworks Innovative Linguistic Solutions
17:00 – End of conference Day 01
14:50 - Re-imagining Dossier Authoring: From Manual Compilation to AI-Assisted Authoring and Lifecycle Management
- AI-driven automation in dossier creation: Transition from time-consuming manual compilation to intelligent automation where AI tools structure, draft, and validate regulatory dossiers using pre-designed templates as per ICH guidelines and real-time data processing.
- Enhanced compliance and efficiency: AI-assisted authoring ensures alignment with global regulatory standards (e.g., EMA, USFDA, CDSCO) by auto-updating changes in guidance and improving accuracy, traceability, and submission timelines.
- Lifecycle intelligence and version management: Integrating AI into the dossier lifecycle enables continuous monitoring, smart version control, and predictive updates across product changes, fostering a fully connected regulatory ecosystem.
MANASA KASIVAJJULA
CEO and Co-Founder
DeepForrest.ai (A CtrlS Company)
08:30 – Coffee & Registration – An opportunity to meet and to network with your conference colleagues.
VACCINES
09:30 - Adaptive Clinical Trial Design in Vaccines: Strengthening Rapid Pandemic Response
- Conventional clinical trials with rigid designs with large sample sizes are time consuming and costly. They often have low positive predictive value, implying that they can fail to detect ineffective products early in clinical development, leading to a waste of time, money, and resources.
- Adaptive Clinical Trial (ACT) designs are increasingly being employed as part of the clinical development plan for infectious disease vaccines, especially during health emergencies.
- The benefits of adaptive and innovative trial designs, when appropriately employed, will allow for more efficient and less costly vaccine development. This enhances the greater sustainability of the vaccine ecosystem and ultimately access to needed vaccines not yet available in developing countries.
MANISH MAHAJAN
Zydus Group
IMPACT OF TECHNOLOGY
10:10 – Keynote Panel Discussion: Technology and Innovation in Clinical Trials: Turning Potential into Practice. Opportunities, Risks, and Reality. AI & other Emerging Tech
Moderator
RASHMI HEGDE
GSK (Former)
Panellists
RUSHABH MEHTA
SIROai
SIVA KUMAR BUDDHA
Amgen
SUCHITA MORE
MSD
PROTITI BAGCHI
GSK
MANGALA KOTNIS
Abbott (Former)
11:00 – Morning Coffee/Tea & Discussion
RWE & RWD
11:30 – DISCUSSION WITH EXPERTS: From Data to Decisions: Unlocking the Value of RWE and RWD in Modern Clinical Trials. What It Really Takes to Use Them Right?
Moderator
KAVITA LAMROR
Maxis Clinical
Panellists
SHALINI MENON
GSK
PANKAJ THAKUR
Hetero Labs
MAYUR MAYBHATE
Alkem Laboratories
DYOTONA SEN
Galderma
SHRADDHA BHANGE
Sandoz
MANGALA KOTNIS
Abbott (Former)
12:20 – Reserved for Gold Partner
For sponsorship opportunities please contact
info@virtueinsight.com
SHEFALI JOBANPUTRA
Takeda
12:50 – Networking luncheon
COMPLIANCE / INSPECTION / RISK MANAGEMENT
14:00 – DISCUSSION WITH EXPERTS: Staying Inspection-Ready - From Risk to Readiness: Building a Culture of Compliance in Clinical Trials
Moderator
RENUKA NEOGI
Sun Pharma
Panellists
RAJESH GAIKWAD
Dr. Reddy's Laboratories
SWAPNALI RAUT
GSK
RUTEJA JOGLEKAR
AstraZeneca
SOURABH FULMALI
Sanofi CHC India
KAPIL MEHTA
JB Pharmaceuticals
MANGALA KOTNIS
Abbott (Former)
RBQM
14:50 –From Information to Insights: Harnessing Centralized Monitoring in RBQM to proactively identify and mitigate risks in Clinical Trials.
- Increasing complexity of clinical trial data and the need for stronger quality oversight.
- Centralized Monitoring (CM) supporting RBQM through CtQFs, KRIs, and QTLs.
- Proactive detection of risks and outliers to improve trial data reliability and subject safety.
- Case studies demonstrating practical application of RBQM principles.
- Regulatory, statistical, and implementation aspects of RBQM in modern clinical trials.
PRIYANGSHU CHOWDHURY
GSK
BISMITA BORKAKOTY
GSK
15:30 – Afternoon Tea/Coffee
REGULATORY
16:00 – Keynote Panel Discussion: Advancing Clinical Trials in India: Enabling Faster and Safer Clinical Trials. Regulatory Reforms Shaping the Future.
Moderator
MILIND ANTANI
Nishith Desai Associates
Panellists
MAYUR PARMAR
FDA
Jitendra Dixit
Takeda Pharmaceuticals
KEDAR SUVARNAPATHAKI
Johnson & Johnson
AKSHAYA ODAK
Lupin
MARTINA GOMES
Bayer
HARSHAD KOTHAWADE
Merck Group (Former)
MANGALA KOTNIS
Abbott (Former)
17:00 – Closing remarks and End of conference
Our Partners
We sincerely thank the following organizations and individuals for generously contributing their time, financial support, ideas, and dedication toward the successful conduct of the 17th Annual Clinical Trials Summit 2026
Principal Partner
Silver Partner
Exhibitors
Lanyard Partner
Event Venue
World Trade Center (WTC)
Mumbai
India
022 6638 7272
Get Involved
Networking App
Kindly Note!
Access to view and connect with other attendees through our mobile app will be enabled closer to the conference date.
Pricing Details
STANDARD PRICE
PRICE — INR 19,000 + GST (18%) PER DELEGATE (Valid till 10 June 2026)
You can simply email or call and book your conference delegate seats on:
TEL: + 91 44 4210 8101 (or) Email — info@virtueinsight.com
Accommodation
We have secured special room rates for our conference participants who wish to stay at “The Taj President Hotel” during the conference dates, which is conveniently located next to the conference venue at the World Trade Centre.
Once you confirm your participation, our operations team will share the room reservation details along with the booking deadline and the special rates we’ve arranged.
Event Testimonials
Great Support Team
Conference was very informative and the positive of the conference is Mr. Bangarurajan sir. Regulatory perspectives were very much good and clarified. Very much happy for the conference
Research Associate, The Himalaya Drug Company
Very Powerful
Very well structured summit. Adequate knowledge on the topic of clinical research, regulations, guidelines, amendments, etc are well discussed
ICRI (Institute of Clinical Research, India)
Excellent Service
Very informative. Good refresher on latest guidelines. Good conference for networking
Co-ordinator, CDSA-CCRE
Excellent Service
Nice and arranged and organised well
Vice President, Mascot Spincontrol
Very Powerful
It was a fantastic event and many congratulations for bringing in thought leaders to a common platform. We wish to come on board as a gold partner for next year and I am making a business case to convince our management
CRO Services, Techsol Lifesciences
Great Support Team
It was an exceptional experience! This conference exceeded my expectations in every aspect, from the quality of the presentations to the overall organization and networking opportunities. The summit brought together an impressive lineup of industry experts, thought leaders, and professionals from various domains of clinical research.
The content of the presentations was highly informative and thought-provoking. I was particularly impressed by the depth of knowledge showcased by the speakers, who provided practical strategies and solutions to address the challenges faced in the clinical trial landscape. The networking opportunities at the summit were truly exceptional. I must commend the Virtue Insight team for their impeccable organization and attention to detail. From the seamless registration process to the flawless execution of the conference, everything was meticulously planned and executed. The venue was well-equipped, and the logistics were taken care of, ensuring a comfortable and enjoyable experience for all attendees.
Overall, the 14th Annual Clinical Trial Summit 2023 by Virtue Insight was a resounding success. Kudos to the Virtue Insight team for organizing such a remarkable event, and I eagerly look forward to attending future conferences by Virtue Insight!
Vice President, Tech Observer
Excellent Service
It was an amazing event and thank you for all the support.
Sales Director, CRYOPDP
Very Powerful
Excellent Execution and Management. Day 2 was excellent, overall the conference this year was very good than the one held last year (2024)
Sr. Manager - Local Clinical Operations, Boehringer Ingelheim
Great Support Team
Emphasizing on DCT, Challenges & Effective site management, RWD impact on research were one of the game changing topics in CR. Overall prediction of market for CR till 2034. Insightful Conference
Associate, Clinical Operations, Arcolab
United Kingdom
Block 3, 86 Coombe Road
Croydon CR0 5RA
London, UK
Asia
Plot No – 07 – 2nd Floor
Ekambaram Industrial Estate
Alapakkam, Porur Chennai,
India – 600 116
Download App